The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers Banner

The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers

The Federal Trade Commission and the U.S. Department of Justice, Antitrust Division, will host a two-day virtual workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. The workshop, organized by FTC and DOJ staff, offices of state attorneys general, and international enforcement partners, will take place virtually from 9:00am to 12:00pm EDT on Tuesday, June 14 and 9:00am – 11:30am on Wednesday, June 15.

The workshop is the culmination of the Multilateral Pharmaceutical Merger Task Force, formed in March 2021 by then-Acting Chairwoman Rebecca Kelly Slaughter to consider how to address the varied competitive concerns that pharmaceutical mergers and acquisitions raise. Members of the Task Force include staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S. Department of Justice’s Antitrust Division, and Offices of State Attorneys General.

The workshop will feature a keynote delivered by Commissioner Slaughter and panels organized by Task Force members. Commissioner Slaughter’s keynote will start the first day of the workshop, followed by plenary sessions on market concentration in the pharmaceutical sector and merger remedies. The second day will feature sessions on innovation aspects of pharmaceutical mergers and how conduct by pharmaceutical companies affects merger analysis.

The virtual workshop is open to the public and registration is not required. We encourage health policy experts, economists, attorneys, scientists, healthcare practitioners, academics, consumers, and other interested persons to view the live webcast.

The Future of Pharmaceuticals - Tuesday, June 14

9:00 – 9:15 AM Welcome & Introduction 9:15 – 9:30 AM Keynote by Commissioner Rebecca Kelly Slaughter 9:30 – 10:30 AM Presentation #1: Concentration Levels in the Pharmaceutical Sector (FTC/DOJ) Panelists: Rena Contin (Boston University School of Business) Patricia Danzon (University of Pennsylvania) Diana Moss (American Antitrust Institute) Moderator: Sarah Allen (DOJ) 10:30 – 10:45 AM Break 10:45 – 11:45 AM Presentation #2: Remedies (State AG Partners) Panelists: Arti Rai (Duke Law) Barak Richman (Duke Law) Robin Feldman (UC Hastings Law) Youenn Beaudouin (European Commission, Directorate-General (DG) for Competition) FTC Person Moderator: Malinda Lee (California Attorney General) 11:45 AM – 12:00 PM Closing of Day 1

The Future of Pharmaceuticals - Wednesday, June 15

9:00 – 9:05 AM Welcome Viola Chen, U.S. Federal Trade Commission 9:05 – 10:05 AM Assessment of Innovation Aspects in Pharmaceutical Mergers Panelists: Carmine Ornaghi, University of Southampton Paul Csiszár, European Commission Directorate-General for Competition Elie Yoo, U.K. Competition and Markets Authority Camille Vardon, European Commission Directorate-General for Competition Caroline Holland, U.S. Federal Trade Commission Moderator:
 Riccardo Ferrari, U.K. Competition and Markets Authority 10:05 – 10:20 AM Break 10:20 – 11:20 AM Prior Bad Acts as Factors in Pharmaceutical Merger Reviews Panelists: Gwendolyn Cooley, Wisconsin Attorney General’s Office Michael Carrier, Rutgers Law School Scott Hemphill, NYU School of Law Raksha Kopparam, Washington Center for Equitable Growth Moderator: David Lawrence, U.S. Department of Justice 11:20 – 11:30 AM Closing of Day 2 Anupama Sawkar, U.S. Federal Trade Commission